Our next presenter is none other than the CEO from Mach7 Technologies, Teri Thomas. Good morning, Teri.
Good morning, John. How are you?
I'm very well, thank you. Prior to joining Mach7, Teri was the CEO of Volpara Health Technologies, a company also involved in the broader medical imaging sector, which she led from being a perpetual loss maker to profitability and ultimately to a successful sale. Mach7 develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, and the Middle East. Its leading product is the eUnity Enterprise Viewer, which Teri will tell us about in greater detail shortly. But essentially, this software is a key component of the hospital picture archiving and communications system, or PACS system, and it is a core driver of revenues. After a year in the job, Teri has completed a ground-up rebuild of the company and is now starting to recover lost ground.
Last week, the group announced its first significant win under her leadership with the signing of the Temple Health contract for the vendor-neutral archive. Congratulations on that milestone, Teri, and welcome to the conference.
Thank you very much. I appreciate it.
Teri, it has been, like I said, 12 months. It has been a, at times, difficult journey for you, but you have come through the other side of it smiling and now on a platform for growth.
Absolutely.
Good. Now, Teri, have you got some slides? Are we going to run through those, or where are we now?
I do have some slides, and Justin, I had them up a minute ago. I have the clicker, but I Dark screen, so my team managed-
All right, well, just while we're getting that-
Oh, there we go. Okay.
There, you got them?
Thank you, Justin. Yeah, happy to walk through a little bit about Mach7 and then have a little chat. First of all, standard disclaimer, of course. For those of you that have been on for a bit, I was listening in a bit as well, you just heard Sam from Pro Medicus describe a fairly exciting and growing imaging market, and I think it'd be nice to explain where Mach7 fits and where I see our opportunity to grow. I like to say we complete the patient's picture with the patient's pictures. A radiologist needs excellent tools to read radiology images. However, across the rest of the hospital, people need access to all types of images, radiology, but all kinds of others as well. They need images from lots of places. Sam mentioned cardiology, but there's also endoscopy, point-of-care ultrasound, bedside ultrasound, photographs, videos.
There are tons of different places that images are. In most healthcare systems in the world right now, lots of different systems. Getting those images together and making them available in the patient's record, keeping the hospital in control of what they do so that you can actually see the full picture of the patient, Mach7 exists to do. Our growth opportunity as a company is to become more useful across the entire enterprise. Complete that patient's picture. We think about patients moving through the health system. Their images might be video, wound photographs. Clinicians should be able to find the relevant images without chasing someone down. The other thing that's important, and I think Sam mentioned this too, is that the systems have been built up over decades, and a lot of the tech in hospitals right now is 5, 10, 15, 20 years old.
A lot of the integrated delivery networks and health systems in the United States, our biggest market, have grown through acquisition, adding departments, adding hospitals, adding ambulatory, and they brought in-house all kinds of different systems that were purchased for different jobs. We ask our customers what they need to connect, what's costing them time, and how we can improve the clinician experience while keeping the systems in place that are working well. We also ask how infrastructure can help our customers use the newest technology and evolve, including commercial AI, their own AI, and third-party AI. These are practical customers. Our health systems with multiple hospitals and sites, complex imaging environments, and they need to make images available across all of the clinical teams. Academic medical centers and organizations using Epic are particularly relevant to us.
We also serve imaging providers where our existing products solve really clear operational problems. For a health system-wide decision, the technology leadership and clinical leaders both have priorities that need to be addressed. One, cost, security, and how systems fit together. They want to minimize complexity, streamline things. IT talent is a pain point in our industry. The other, the clinicians really care about whether the images are where a patient needs them, when the clinician is sitting there with the patient, and that they're there fast. We, as a company, with our universal viewer and our VNA, satisfy both of these. However, we do choose our opportunities carefully. A hospital with several disconnected imaging systems is a much more natural prospect for us than a buyer whose only requirement is the most sophisticated workstation for a specialist reading room. Our steps, let's see, graded.
Sorry, one second. Oh, I'm ahead on my slides. Sorry, one minute. There we go. All right. Our steps to growth in order to speed of revenue. We have four different big growth initiatives. First is to protect and expand our existing customers. They already know us, they use our technology, and there's room to grow through more sites, more imaging volume, and additional products. A customer may need our archive, an archive customer may benefit from our viewer, and either of them can use our new modules. This is our closest opportunity for revenue, and we've invested a lot in the last year in current customer engagements, understanding our customers' needs, and delivering something useful for them. A big focus for us that drives development, lots of our customers are speaking directly with our developers, and our support people are integrated in our development processes.
Second, focusing on winning new customers with products that we deliver today. We're strengthening our commercial coverage, and we're focusing on prospects that are a really clear fit, using customer references to demonstrate what we can do and spur new innovations. A key focus for us is true differentiation, not chasing after lines in an RFP, but seeking to fill the gaps that nobody else covers. That's a key reason for Flamingo, nimble, different. Temple Health is a recent example, as John mentioned. They're an Epic customer, implementing us alongside some other vendors to help make the systems work better together at a lower cost with more flexibility. The third growth area for us is Flamingo, giving us new and existing customers starting points and room to expand with new modules.
Fourth, integration and advisory work is a big need in our industry, particularly around EMR integration, system design. Customers are saying, we feel we need to move to the cloud, but we're not comfortable letting go of all of our on-prem systems. So working with them on what's the best go-forward design that is safe, that is available, and that is redundant. Customers want their images available to the patient as well, and across departments and sites. So we can help our customers plan those changes, design the best imaging fabric for the organization, which then creates opportunities to expand with shared customers and engage new ones as partners with aligned outcomes. To support that growth, we do need to deliver useful products faster. Mach7 is our name, seven times the speed of sound.
We are now living up to that name with a big increase in our innovation velocity. AI is helping our team work a lot more efficiently, but anyone can use AI to do software faster, and you could make software nobody uses. So close engagement with our customers helps us choose what to build, validate that this is the direction that is important to them, and ensure that this is commercially viable, things that people will pay for. We're actually getting developers talking with our customers, as well as our product managers and our support teams working very closely with development. The result is useful improvements that customers will adopt, new customers will buy, and both will recommend. So that brings me to a bit about Flamingo. Flamingo is our next-generation architecture with an initial set of five modules that we're showing at RSNA in a couple weeks.
Foundation is the common core. Storage gives customers choices across their own and on-premise deployments using the cloud or a hybrid of both. Worklist brings together work across different sites and enables us to compete better for those who want a full deconstructed PACS stack. Sonar shows the technology team how the imaging platform is performing, and it makes life easier for the IT teams. Flow develops our own routing and automation further, getting images where they need to go using the customer's rules in a next iteration that is easier and lower friction. Customers can modernize in stages, buying the capabilities that they need, building on their existing VNA installs, eUnity installs, or both. For Mach7, that means more to offer our existing customers and also more ways into new accounts.
And as I mentioned, we will be showing the new Flamingo modules at RSNA, which is the world's largest imaging conference. It is in Chicago, in the United States, later this month. This slide reinforces the reason customers buy, because it is not just cool new functionality, but saving money, saving time, and reducing risk are the biggest factors that we see as we do our customer listening tours. And it is not just cool stuff, but what is the impact? So a single worklist means less switching between systems. It is flexible, and it enables smoother workflows across our systems. The Sonar brings monitoring into the platform with the potential to replace separate tools that people pay for right now, saving them money. And then routing reduces the work of moving studies by hand, makes things more reliable and easier to manage.
Customers already value being able to buy our existing routing capability without a complete archive, so Flamingo Flow builds on that with an improved user interface and more flexibility. This new development also creates a strong Foundation for an AI-forward future, and Mach7 can route a study to a third-party AI tool and make results available in the imaging workflow in our viewer. The customer chooses their clinical AI. But ultimately, we want to help organize the widest breadth of imaging data for future AI ingestion, as I expect that will become more and more important in an AI-enabled future. So a large health system can start with a focused purchase, and we are betting that that start will provide useful enough functionality that they choose to do more and more with us over time. I cannot do a presentation to investors without showing our financials.
The financial position we are in really supports our plan and shows a company that is increasingly healthy. At the end of September, our annual recurring revenue run rate, AUD 23.5 million, up 8.5% in constant currency over the prior year, despite doing a wholesale reset of our business. We have nearly AUD 20 million in cash, we have no debt, and we have delivered four consecutive quarters of positive operating cash flow. Receipts were AUD 7.3 million, operating payments AUD 7 million.
We need to maintain that discipline as we invest in our products and commercial growth, but I want to be clear, growth is our focus over cost management. We balance it to be a responsible, sustainable business. Which leads me to all about growth. It is going to be a very strategic RSNA. We are going to be showing more new innovation than Mach7 has shown in years.
This puts a broad set of our staff, from developers, support staff, sales staff, even our board, attending RSNA together, meeting with our customers, prospective customers, and partners in one place. We are going to be demonstrating new Flamingo modules, also, of course, our top industry-rated eUnity viewer, our existing vendor-neutral archive, and we will have a number of already pre-scheduled focused customer and partner meetings. I do want people to leave with a specific next step, having a product evaluation scheduled, an expansion discussion, or a proposal. The return from RSNA really comes from business development and follow-up afterwards. So, looking at from reset to growth, this really lays out our path ahead. Our focus now really is the growth engine, expanding our existing relationships, winning new customers with today's products, but bringing those new Flamingo innovations in to early adopters and new customers joining us.
Next, make that more repeatable through more Flamingo modules, broader customer adoption, and partners helping extend our reach further. Our ambition is to become the imaging data layer that customers rely on across their health systems. Imaging extends through radiology, cardiology, pathology, dental, procedures, photographs, videos. As AI uses more and more of it, customers will need that information accessible and well-governed, and that's where our enterprise focus, plus a strong and growing Epic opportunity, and the Flamingo modules all come together. We have customers and technology base to build upon based on a heritage of strong vendor neutrality. Our job is to turn that into more wins, growing recurring revenue, and cash generation. That's our focus and what I expect that Mach7 will be measured on in the following year. Thank you.
All right, Teri, thank you very much. That was a comprehensive run-through. You've certainly got a lot on your plate. Let's talk about the RSNA conference, which starts a week after next. You're going to have a big focus there on your team, and you've come a long way in the last 12 months. You also talked about your protect and expand strategy, and that's going to be growing your existing base, your revenue base from your existing clients. Tell us a little about those existing clients. Can you start with sort of maybe your largest customer down to your smallest customer, and perhaps just put a bit of description around who that client base is today, and let's start with that.
Sure. We actually support some of the bigger healthcare organizations globally, with the majority of our customers being in the United States. We do have a customer in Hong Kong that's one of the biggest systems in the world. We have archives that have in excess of 30 million studies with multiple images per study. We have customers who are doing 2, 3, 4, 5, 6 million images or studies processed through Mach7 per year. We do have some customers who are very large and very complex. Several of these are complex integrated delivery networks that have grown through acquisition. They may have 20, 30, 40 hospitals and hundreds of providers that actually access images on a day-to-day basis. That's our sweet spot, that's our ideal customer.
We've got a number of those customers that are actively engaged with our developers to ensure that the development that we do meets the needs of this growing segment, particularly in the United States where there's been a lot of health system consolidation. There are fewer and fewer small standalone imaging centers. A lot of those imaging centers have been bought up by PE and banded with others into imaging chains.
Yeah.
Smaller and smaller hospitals banding with other hospitals and either creating clinically integrated networks, virtually integrated networks, or being wholesale acquired into health systems. When we look at the trend in the industry, those big IDNs are the center of our bullseye, often graded or anchored by academic medical centers who have lots of different specialties, but also really complex needs related to imaging. These are ones that have hundreds of sources of images, lots of specialty niche systems. Also a strong requirement of autonomy across the industry-defining researchers in their specialties.
Okay.
These are customers that need what we provide a whole lot more than a single imaging center or a standalone hospital.
Now, in his-
That said-
You go.
Oh. That said, we do actually still have a perfectly happy base of veterinarians, although those we are supporting primarily through working with partnerships because it is not as profitable, and their needs are a little bit different. So, we love all of our customers, but we are focusing our development on those big customers that are going to benefit most from what we do.
Now, in his presentation, which you were listening to, I asked Sam about whether it was just Visage and Sectra being the predominant providers to those very large accounts. But you are targeted to not those accounts. You are very different, quite a different offering to them. Now, you also talked about the industry consolidation. So, given that you have two dominant suppliers there now, Pro Medicus and Sectra, is that a threat to you, or is it an opportunity for you, rather?
It is absolutely an opportunity. We do not choose to compete with Sectra and Visage. I agree that Sectra and Pro Medicus are the ones that are winning the majority of the new PACS selections. We go in alongside. Temple is installing us alongside one of those two vendors.
Yeah.
We actually meet needs that they do not. They do a great job in the premium reading room. They are very focused on, let us provide a really top-tier experience for a radiologist who is day in, day out, doing radiology reading.
Yeah.
Similarly, it is very complicated and difficult also to satisfy a cardiologist who is also going through his cardiology studies or her cardiology studies-
Yeah
-as part of a cardiology workflow. But those vendors are not known for having a strong emphasis on, what is the dental workflow? What is the ophthalmology workflow? How are we doing a really strong Epic Lumens endoscopy workflow in which they are primarily in the Epic space, but they need to make sure the endoscopy videos and associated documentation are incorporated into one strong clinical workflow? Our focus being the broad enterprise, we will ingest images that are stored in Sectra or in Intelerad or Visage or any of these, and we have lots of customers that have those vendors alongside us and quite happily use us as a downtime PACS-
Yeah
-as a supplementary PACS. Our price point is a quite different price point from what you might be paying for some of those premium offerings. People don't get the same reimbursement for a point-of-care ultrasound as they do for a CT scan. They don't want to pay to manage those images at the same rate.
Yeah.
We allow our customers to have one stable base that can then supplement the reading room experience that might be for the radiologist using Sectra or Visage or one of the other good vendors out there. Yet, if somebody, a wound care nurse, is in the middle of an EHR workflow and they need to pop up an image, they don't have to necessarily go to Sectra to get it. They can get it directly from Mach7.
Okay.
That's our strategy, is to actually supplement and provide something that is focused heavily on connectivity and breadth.
Okay. It's a pretty complex field that you're selling into. You talked about also doing some consulting work. It sounds like there is an awful lot of that work to be had because, like you say, you've got lots of large systems that have built up through multiple acquisitions, multiple different systems.
Yeah.
And you're trying to deal with a poor old CTO who's got to consolidate all the systems.
Yeah.
And make it all hang together. What's your expectation coming into RSNA next week for your ability to sell some of these different services, and where is going to be your sort of focus, I suppose, for the low-hanging opportunities?
I mentioned in my opening comments about doing a listening tour. I myself went out and visited over a dozen of our customers, and a number of our leaders have visited with some of our biggest customers and simply asked them, what's working well and what's not? What are the gaps?
Yeah.
What do you need? Some of the gaps are functionality. Being able to pull these different systems together, I was really shocked that a customer presented their imaging environment, and the complexity blew my mind. I've actually gotten their permission to share with some de-identification, share their slide at our AGM-
Okay.
-so that people can see what kind of situations these CIOs are inheriting as they're acquiring hospitals and trying to pull the systems together. I also was really surprised to hear customers say that it's routine to have half a dozen, a dozen, one customer said they even have 18 copies of a single image.
Yeah.
Which gets quite expensive when these images take up a lot of space. Driving what we're showing at RSNA is a direct result of that listening tour and what customers said they need and gaps that we're filling that they tell us other vendors don't do well or do only to a certain point, but not enough for them to start decommissioning other systems and reducing that complexity.
I expect more consulting work. The two areas customers have said is, can you come in, spend a week with us, analyze our entire environment, look at all of these systems? They've said they don't want some of the big box vendors to do it because they've got a motivation to be able to push everything to their solution, whereas we don't actually care where these systems, what you have for AI, what you have for CT, what you have for MRI. We lean in hard on vendor neutrality. But to create a design with the customer, an architecture in which we can prioritize with them simplifying their imaging environment.
The Flamingo module integration, the really robust and comprehensive VNA that can do DICOM wrapping and analyze the metadata associated with the actual pixels, the routing rules that we provide, which I hear are stronger than anyone else has, enables us to make up for some of the deficiencies in the other systems and reduce the complexity of those environments. The other thing people have said to us is, my leadership says I need to move to the cloud. Some of our customers have had problems with cloud downtime-
Yeah.
-and diverting patients. So, they want to know if they are going forward with a cloud-forward provider, what their backup plan is if something happens? Creating architecture that has multiple levels of redundancy is another big need our customers have expressed, and an area that we are happy to start fulfilling after RSNA.
Okay. Just last question because we are out of time. Temple Health was a great win. Tell us quickly about them and what your expectation is for growth of revenues out of that client.
I do want to correct, it is my third new customer.
Oh, well, I do stand corrected.
Not my first, it is my most recent.
Okay.
Temple Health is a perfect example of the ideal customer for us in that they are an academic organization with a lot of complexity. They are an Epic shop, and most of our IDN customers also use Epic, so we are working collaboratively with Epic on a number of Epic enhancement workflows to be able to bring imaging into the EMR in a seamless way across multiple specialties. Temple coming to us with, we have got lots of different departments, we have got a good degree of complexity. We are installing one of those vendors that was mentioned as-
Yeah.
-dominating in the radiology space. Mach7 is the way to pull it all together into a lower cost, higher availability, and less complex environment across the enterprise is absolutely our direction forward.
Okay.
We've got several others in the pipeline that we think will benefit from the work that we're doing with them and the work that we're doing with Epic.
All right then, Teri. Well, thank you very much for your time this morning. It's great to have you on the conference for the first time, and we look forward to seeing you again soon. We're going to take a short break, and we will be back with Thomas Wakim. Thank you.